In an era of remote care and expanding access to men’s health treatments, it would seem as if erectile dysfunction (ED) is easier to talk about. But, for many men, ED remains challenging to treat. New ...
Rx-to-OTC is emerging as a substantial self-care industry among pharmaceutical companies, it is expected to reach $66.5 billion by 2033. Petros deprioritized Peyronie's disease deal due to focus on ...
Erectile dysfunction drug prescriptions down 5 percent, after rising for years. June 9, 2011— -- Sales of the little blue pill that promised men they could be sexually active well into their 70s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results